How have VLRXQ shares performed in 2024?

Valeritas' stock was trading at $0.02 at the beginning of the year. Since then, VLRXQ shares have increased by 0.0% and is now trading at $0.02. View the best growth stocks for 2024 here .

How were Valeritas' earnings last quarter?

Valeritas Holdings, Inc. (OTCMKTS:VLRXQ) posted its quarterly earnings results on Tuesday, November, 12th. The company reported ($1.91) EPS for the quarter, beating the consensus estimate of ($2.52) by $0.61. The company had revenue of $8.46 million for the quarter.

How do I buy shares of Valeritas?

Shares of VLRXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:VLRXQ

Valeritas (VLRXQ) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free VLRXQ Stock Alerts

$0.02

0.00 (0.00%)

(As of 07/1/2020)

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.02
▼
$0.02
52-Week Range: $0.01
▼
$4.28

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Valeritas alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Valeritas Stock (OTCMKTS:VLRXQ)

Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

VLRXQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

VLRXQ Stock News Headlines

June 20, 2023 | investing.com

Valeritas Holdings Inc (VLRXQ)

October 13, 2022 | finance.yahoo.com

Wearable Injectors Market sales are expected to reach US$ 17.6 Bn by 2031 – Persistence Market Research - Yahoo Finance

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

October 13, 2022 | benzinga.com

Wearable Injectors Market sales are expected to reach US$ 17.6 Bn by 2031 – Persistence Market Research - Benzinga

September 23, 2022 | finance.yahoo.com

Wearable Injectors Market Size to Hit $13485.22 Million by 2028 | Wearable Injectors industry Share to Rise at 16.90% CAGR during 2022 - 2028, Says Facts & Factors - Yahoo Finance

September 23, 2022 | globenewswire.com

Wearable Injectors Market Size to Hit $13485.22 Million by 2028 - GlobeNewswire

September 14, 2022 | benzinga.com

Insulin Pump Market to hit US$ 18.05 Billion by 2030 | Exclusive Report by Growth Plus Reports - Benzinga

August 23, 2022 | finance.yahoo.com

Global Insulin Patch Pumps Market Report 2022: Market is Expected to Reach $1.63 Billion in 2026 at a CAGR of 8.58% - Long-term Forecast to 2031 - Yahoo Finance

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

August 22, 2022 | globenewswire.com

Global Insulin Patch Pumps Market Report 2022: Market is Expected to Reach $1.63 Billion in 2026 at a CAGR of 8.58% - Long-term Forecast to 2031 - GlobeNewswire

August 19, 2022 | finance.yahoo.com

Global Insulin Patch Pumps Market Report 2022-2026 & 2031 - Integration with Smartphones and Enabling Automation Gaining Traction - Yahoo Finance

July 26, 2022 | businesswire.com

Wearable Injectors Global Market Report 2022: Market is Expected to Grow to $11.29 Billion in 2026 at a CAGR of 12% - Long-term Forecast to 2031 - ResearchAndMarkets.com - Business Wire

July 14, 2022 | benzinga.com

Global Wearable Injectors Market (2022 to 2028) - Size, Share & Industry Trends Analysis Report - Benzinga

July 11, 2022 | benzinga.com

Insights on the Wearable Injectors Global Market to 2028 - Rising Consumer Preference for Home Care Solutions is Driving Growth - Benzinga

July 6, 2022 | businesswire.com

Global Insulin Pens, Syringes, Pumps And Injectors Market Report 2022: Increase in the Prevalence of Diabetes Globally is Driving Growth - ResearchAndMarkets.com - Business Wire

July 4, 2022 | finance.yahoo.com

A $18.8 Billion Global Opportunity for Self-care Medical Devices by 2026 - New Research from StrategyR - Yahoo Finance

June 29, 2022 | globenewswire.com

Insights on the Ultra large Volume Wearable Injectors Global Market to 2027 - Featuring Amgen, BASF and Insulet Among Others - GlobeNewswire

June 27, 2022 | finance.yahoo.com

Insights on the Ultra large Volume Wearable Injectors Global Market to 2027 - Featuring Amgen, BASF and Insulet Among Others - Yahoo Finance

June 18, 2022 | gurufocus.com

Apexigen Appoints William Duke as Chief Financial Officer - GuruFocus.com

June 15, 2022 | benzinga.com

Diabetes Devices Market Value to Reach $54.16 Billion by 2030: Grand View Research, Inc. - Benzinga - Benzinga

June 8, 2022 | globenewswire.com

Apexigen Appoints William Duke as Chief Financial Officer - GlobeNewswire

June 3, 2022 | businesswire.com

Microneedle Drug Delivery Systems Global Market Research Report 2022 - ResearchAndMarkets.com - Business Wire

May 24, 2022 | finance.yahoo.com

Microneedle Drug Delivery Systems Global Market Report 2022 - Yahoo Finance

May 24, 2022 | finance.yahoo.com

Wearable Injectors Global Market Report 2022 - Yahoo Finance

May 24, 2022 | globenewswire.com

Wearable Injectors Global Market Report 2022 - GlobeNewswire

May 23, 2022 | globenewswire.com

Autoinjectors Market to reach 238.7 billion in 2030 with a CAGR of around 17.9% asserts Strategic Market Research. Lets make you acquainted with some of the most crucial statistics related to this market. - GlobeNewswire

April 6, 2022 | finance.yahoo.com

Micro-Needle Patch Market to Reach Value of USD 1,034.5 Million in 2028 | Increasing Government Funding and Rise in the Diabetic Population All Over the World are Key Factors Driving Industry Demand, Says Emergen Research - Yahoo Finance

See More Headlines

Receive VLRXQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Valeritas and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/12/2019
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: OTCMKTS:VLRXQ
CUSIP: N/A
CIK: 1619250
Web: www.valeritas.com
Phone: 908-927-9920
Fax: 908-927-9927
Employees: 125
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Mr. John E. Timberlake (Age 54)
Pres, CEO & Director
Mr. Erick J. Lucera CPA (Age 51)
CFA, CFO & Sec.
Mr. Geoffrey H. Jenkins (Age 67)
Exec. VP of Manufacturing, Operations and R&D
Dr. Matthew H. Nguyen (Age 49)
Chief Commercial Officer
Mr. Scott A. Huie
VP of Regulatory Affairs/Quality Assurance and Compliance

Key Competitors

View All Competitors

VLRXQ Stock Analysis - Frequently Asked Questions

How have VLRXQ shares performed in 2024?: Valeritas' stock was trading at $0.02 at the beginning of the year. Since then, VLRXQ shares have increased by 0.0% and is now trading at $0.02.
View the best growth stocks for 2024 here.
How were Valeritas' earnings last quarter?: Valeritas Holdings, Inc. (OTCMKTS:VLRXQ) posted its quarterly earnings results on Tuesday, November, 12th. The company reported ($1.91) EPS for the quarter, beating the consensus estimate of ($2.52) by $0.61. The company had revenue of $8.46 million for the quarter.
How do I buy shares of Valeritas?: Shares of VLRXQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:VLRXQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial